NCT00002332View on ClinicalTrials.gov

A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Thymopentin

Trial Locations (3)

15206

Novum Inc, Pittsburgh

91356

Dr Jeffrey Galpin, Tarzana

94115

Dr Marcus Conant, San Francisco

Sponsors
All Listed Sponsors
lead

Immunobiology Research Institute

INDUSTRY

NCT00002332 - A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs | Biotech Hunter | Biotech Hunter